Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affects tens of millions worldwide; the causes of exertional intolerance are poorly understood. The ME/CFS label overlaps with postural orthostatic tachycardia (POTS) and fibromyalgia, and objective evidence of small fiber neuropathy (SFN)...

Full description

Saved in:
Bibliographic Details
Published in:Chest Vol. 160; no. 2; p. 642
Main Authors: Joseph, Phillip, Arevalo, Carlo, Oliveira, Rudolf K F, Faria-Urbina, Mariana, Felsenstein, Donna, Oaklander, Anne Louise, Systrom, David M
Format: Journal Article
Language:English
Published: United States 01.08.2021
Subjects:
ISSN:1931-3543, 1931-3543
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affects tens of millions worldwide; the causes of exertional intolerance are poorly understood. The ME/CFS label overlaps with postural orthostatic tachycardia (POTS) and fibromyalgia, and objective evidence of small fiber neuropathy (SFN) is reported in approximately 50% of POTS and fibromyalgia patients. Can invasive cardiopulmonary exercise testing (iCPET) and PGP9.5-immunolabeled lower-leg skin biopsies inform the pathophysiology of ME/CFS exertional intolerance and potential relationships with SFN? We analyzed 1,516 upright invasive iCPETs performed to investigate exertional intolerance. After excluding patients with intrinsic heart or lung disease and selecting those with right atrial pressures (RAP) <6.5 mm Hg, results from 160 patients meeting ME/CFS criteria who had skin biopsy test results were compared with 36 control subjects. Rest-to-peak changes in cardiac output (Qc) were compared with oxygen uptake (Qc/VO slope) to identify participants with low, normal, or high pulmonary blood flow by Qc/VO tertiles. During exercise, the 160 ME/CFS patients averaged lower RAP (1.9 ± 2 vs 8.3 ± 1.5; P < .0001) and peak VO (80% ± 21% vs 101.4% ± 17%; P < .0001) than control subjects. The low-flow tertile had lower peak Qc than the normal and high-flow tertiles (88.4% ± 19% vs 99.5% ± 23.8% vs 99.9% ± 19.5% predicted; P < .01). In contrast, systemic oxygen extraction was impaired in high-flow vs low- and normal-flow participants (0.74% ± 0.1% vs 0.88 ± 0.11 vs 0.86 ± 0.1; P < .0001) in association with peripheral left-to-right shunting. Among the 160 ME/CFS patient biopsies, 31% were consistent with SFN (epidermal innervation ≤5.0% of predicted; P < .0001). Denervation severity did not correlate with exertional measures. These results identify two types of peripheral neurovascular dysregulation that are biologically plausible contributors to ME/CFS exertional intolerance-depressed Qc from impaired venous return, and impaired peripheral oxygen extraction. In patients with small-fiber pathology, neuropathic dysregulation causing microvascular dilation may limit exertion by shunting oxygenated blood from capillary beds and reducing cardiac return.
AbstractList Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affects tens of millions worldwide; the causes of exertional intolerance are poorly understood. The ME/CFS label overlaps with postural orthostatic tachycardia (POTS) and fibromyalgia, and objective evidence of small fiber neuropathy (SFN) is reported in approximately 50% of POTS and fibromyalgia patients. Can invasive cardiopulmonary exercise testing (iCPET) and PGP9.5-immunolabeled lower-leg skin biopsies inform the pathophysiology of ME/CFS exertional intolerance and potential relationships with SFN? We analyzed 1,516 upright invasive iCPETs performed to investigate exertional intolerance. After excluding patients with intrinsic heart or lung disease and selecting those with right atrial pressures (RAP) <6.5 mm Hg, results from 160 patients meeting ME/CFS criteria who had skin biopsy test results were compared with 36 control subjects. Rest-to-peak changes in cardiac output (Qc) were compared with oxygen uptake (Qc/VO slope) to identify participants with low, normal, or high pulmonary blood flow by Qc/VO tertiles. During exercise, the 160 ME/CFS patients averaged lower RAP (1.9 ± 2 vs 8.3 ± 1.5; P < .0001) and peak VO (80% ± 21% vs 101.4% ± 17%; P < .0001) than control subjects. The low-flow tertile had lower peak Qc than the normal and high-flow tertiles (88.4% ± 19% vs 99.5% ± 23.8% vs 99.9% ± 19.5% predicted; P < .01). In contrast, systemic oxygen extraction was impaired in high-flow vs low- and normal-flow participants (0.74% ± 0.1% vs 0.88 ± 0.11 vs 0.86 ± 0.1; P < .0001) in association with peripheral left-to-right shunting. Among the 160 ME/CFS patient biopsies, 31% were consistent with SFN (epidermal innervation ≤5.0% of predicted; P < .0001). Denervation severity did not correlate with exertional measures. These results identify two types of peripheral neurovascular dysregulation that are biologically plausible contributors to ME/CFS exertional intolerance-depressed Qc from impaired venous return, and impaired peripheral oxygen extraction. In patients with small-fiber pathology, neuropathic dysregulation causing microvascular dilation may limit exertion by shunting oxygenated blood from capillary beds and reducing cardiac return.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affects tens of millions worldwide; the causes of exertional intolerance are poorly understood. The ME/CFS label overlaps with postural orthostatic tachycardia (POTS) and fibromyalgia, and objective evidence of small fiber neuropathy (SFN) is reported in approximately 50% of POTS and fibromyalgia patients.BACKGROUNDMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affects tens of millions worldwide; the causes of exertional intolerance are poorly understood. The ME/CFS label overlaps with postural orthostatic tachycardia (POTS) and fibromyalgia, and objective evidence of small fiber neuropathy (SFN) is reported in approximately 50% of POTS and fibromyalgia patients.Can invasive cardiopulmonary exercise testing (iCPET) and PGP9.5-immunolabeled lower-leg skin biopsies inform the pathophysiology of ME/CFS exertional intolerance and potential relationships with SFN?RESEARCH QUESTIONCan invasive cardiopulmonary exercise testing (iCPET) and PGP9.5-immunolabeled lower-leg skin biopsies inform the pathophysiology of ME/CFS exertional intolerance and potential relationships with SFN?We analyzed 1,516 upright invasive iCPETs performed to investigate exertional intolerance. After excluding patients with intrinsic heart or lung disease and selecting those with right atrial pressures (RAP) <6.5 mm Hg, results from 160 patients meeting ME/CFS criteria who had skin biopsy test results were compared with 36 control subjects. Rest-to-peak changes in cardiac output (Qc) were compared with oxygen uptake (Qc/VO2 slope) to identify participants with low, normal, or high pulmonary blood flow by Qc/VO2 tertiles.STUDY DESIGN AND METHODSWe analyzed 1,516 upright invasive iCPETs performed to investigate exertional intolerance. After excluding patients with intrinsic heart or lung disease and selecting those with right atrial pressures (RAP) <6.5 mm Hg, results from 160 patients meeting ME/CFS criteria who had skin biopsy test results were compared with 36 control subjects. Rest-to-peak changes in cardiac output (Qc) were compared with oxygen uptake (Qc/VO2 slope) to identify participants with low, normal, or high pulmonary blood flow by Qc/VO2 tertiles.During exercise, the 160 ME/CFS patients averaged lower RAP (1.9 ± 2 vs 8.3 ± 1.5; P < .0001) and peak VO2 (80% ± 21% vs 101.4% ± 17%; P < .0001) than control subjects. The low-flow tertile had lower peak Qc than the normal and high-flow tertiles (88.4% ± 19% vs 99.5% ± 23.8% vs 99.9% ± 19.5% predicted; P < .01). In contrast, systemic oxygen extraction was impaired in high-flow vs low- and normal-flow participants (0.74% ± 0.1% vs 0.88 ± 0.11 vs 0.86 ± 0.1; P < .0001) in association with peripheral left-to-right shunting. Among the 160 ME/CFS patient biopsies, 31% were consistent with SFN (epidermal innervation ≤5.0% of predicted; P < .0001). Denervation severity did not correlate with exertional measures.RESULTSDuring exercise, the 160 ME/CFS patients averaged lower RAP (1.9 ± 2 vs 8.3 ± 1.5; P < .0001) and peak VO2 (80% ± 21% vs 101.4% ± 17%; P < .0001) than control subjects. The low-flow tertile had lower peak Qc than the normal and high-flow tertiles (88.4% ± 19% vs 99.5% ± 23.8% vs 99.9% ± 19.5% predicted; P < .01). In contrast, systemic oxygen extraction was impaired in high-flow vs low- and normal-flow participants (0.74% ± 0.1% vs 0.88 ± 0.11 vs 0.86 ± 0.1; P < .0001) in association with peripheral left-to-right shunting. Among the 160 ME/CFS patient biopsies, 31% were consistent with SFN (epidermal innervation ≤5.0% of predicted; P < .0001). Denervation severity did not correlate with exertional measures.These results identify two types of peripheral neurovascular dysregulation that are biologically plausible contributors to ME/CFS exertional intolerance-depressed Qc from impaired venous return, and impaired peripheral oxygen extraction. In patients with small-fiber pathology, neuropathic dysregulation causing microvascular dilation may limit exertion by shunting oxygenated blood from capillary beds and reducing cardiac return.INTERPRETATIONThese results identify two types of peripheral neurovascular dysregulation that are biologically plausible contributors to ME/CFS exertional intolerance-depressed Qc from impaired venous return, and impaired peripheral oxygen extraction. In patients with small-fiber pathology, neuropathic dysregulation causing microvascular dilation may limit exertion by shunting oxygenated blood from capillary beds and reducing cardiac return.
Author Felsenstein, Donna
Oaklander, Anne Louise
Systrom, David M
Arevalo, Carlo
Oliveira, Rudolf K F
Joseph, Phillip
Faria-Urbina, Mariana
Author_xml – sequence: 1
  givenname: Phillip
  surname: Joseph
  fullname: Joseph, Phillip
  email: phillip.joseph@yale.edu
  organization: Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Yale-New Haven Hospital, Yale University, New Haven, CT. Electronic address: phillip.joseph@yale.edu
– sequence: 2
  givenname: Carlo
  surname: Arevalo
  fullname: Arevalo, Carlo
  organization: Department of Medicine, University of Rochester Medical Center, Rochester, NY
– sequence: 3
  givenname: Rudolf K F
  surname: Oliveira
  fullname: Oliveira, Rudolf K F
  organization: Division of Respiratory Diseases, Department of Medicine, Federal University of Sao Paulo (UNIFESP), Sao Paulo, Brazil
– sequence: 4
  givenname: Mariana
  surname: Faria-Urbina
  fullname: Faria-Urbina, Mariana
  organization: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
– sequence: 5
  givenname: Donna
  surname: Felsenstein
  fullname: Felsenstein, Donna
  organization: Infectious Diseases Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA
– sequence: 6
  givenname: Anne Louise
  surname: Oaklander
  fullname: Oaklander, Anne Louise
  organization: Department of Neurology, Massachusetts General Hospital, Boston, MA; Department of Pathology (Neuropathology), Massachusetts General Hospital, Boston, MA
– sequence: 7
  givenname: David M
  surname: Systrom
  fullname: Systrom, David M
  organization: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33577778$$D View this record in MEDLINE/PubMed
BookMark eNpNUG1LwzAQDjJxL_oLBMlHv7TLy9omH2VsOpgoOPFjSdO0zWiT2rTD4p834ASPgzvuee6eu5uDibFGAXCLUYgRjpfHUFbK9SFBBIfIOyMXYIY5xQGNVnTyL5-CuXNHhBDGPL4CU0qjxBubge-dcbqsege3nW3gzpyE0ycF16LLtW2HurFGdCPcfKlOaqfgwUtqU0JbwFfRa2V864fuK_g8irrUEm6MVG0latuMqta9dst11Vnjka3nl4OCb6PJvZi6BpeFqJ26OccFeN9uDuunYP_yuFs_7AMZYdwHksWxoHGBME0KmjDEc8qzokAKJ76ScS6ZRAVjCctIRHgWM-YxwnkWMVRQsgD3v3Pbzn4Ofv-00U6quhZG2cGlZMU4iQmisafenalD1qg8bTvd-PPTv4eRH0L2cgc
CitedBy_id crossref_primary_10_1038_s44161_023_00414_8
crossref_primary_10_1007_s10067_023_06743_0
crossref_primary_10_1111_ane_13591
crossref_primary_10_1007_s00108_022_01369_x
crossref_primary_10_1002_jcsm_13669
crossref_primary_10_3390_medicina58121807
crossref_primary_10_1007_s00112_025_02222_9
crossref_primary_10_1016_j_jesf_2024_05_003
crossref_primary_10_3233_WOR_220512
crossref_primary_10_1186_s12967_024_05410_5
crossref_primary_10_1186_s12967_024_05412_3
crossref_primary_10_1016_j_ebr_2024_100682
crossref_primary_10_1007_s11606_024_09290_9
crossref_primary_10_1186_s12933_024_02315_x
crossref_primary_10_3390_jcm13247726
crossref_primary_10_1016_j_chest_2022_04_146
crossref_primary_10_1016_j_hfc_2024_08_002
crossref_primary_10_1002_mus_28013
crossref_primary_10_1080_21641846_2025_2455876
crossref_primary_10_1001_jamanetworkopen_2022_36057
crossref_primary_10_1097_BOR_0000000000001070
crossref_primary_10_1186_s13063_024_08077_x
crossref_primary_10_3390_medicina60020194
crossref_primary_10_14814_phy2_70535
crossref_primary_10_1016_j_ibneur_2023_04_005
crossref_primary_10_1016_j_tem_2024_11_008
crossref_primary_10_1007_s15010_024_02386_8
crossref_primary_10_3390_jcm12227157
crossref_primary_10_1111_joim_13792
crossref_primary_10_1371_journal_pone_0272703
crossref_primary_10_1161_JAHA_121_024207
crossref_primary_10_3389_fcimb_2023_1280600
crossref_primary_10_3389_fneur_2025_1567708
crossref_primary_10_3390_biomedicines9111724
crossref_primary_10_1055_a_1849_8953
crossref_primary_10_1097_SPV_0000000000001240
crossref_primary_10_3389_fneur_2023_1247698
crossref_primary_10_2147_JPR_S394321
crossref_primary_10_1111_eci_14343
crossref_primary_10_1042_BCJ20220154
crossref_primary_10_1111_ene_70321
crossref_primary_10_1212_NXI_0000000000200244
crossref_primary_10_3389_fmolb_2023_1157651
crossref_primary_10_1016_j_chest_2023_03_049
crossref_primary_10_3390_medicina60010083
crossref_primary_10_37615_retic_v7n3a3
crossref_primary_10_1055_s_0043_1770362
crossref_primary_10_1183_13993003_01739_2022
crossref_primary_10_1016_j_blre_2023_101075
crossref_primary_10_3389_fmed_2023_1187163
crossref_primary_10_3389_fneur_2025_1601599
crossref_primary_10_1016_j_mayocp_2023_07_032
crossref_primary_10_3389_fmed_2022_917019
crossref_primary_10_1016_j_chpulm_2023_100010
crossref_primary_10_1016_j_chest_2021_08_010
crossref_primary_10_3389_fresc_2023_1122673
crossref_primary_10_3389_fmed_2025_1607353
crossref_primary_10_3389_fnins_2025_1637838
crossref_primary_10_1097_j_pain_0000000000003260
crossref_primary_10_1007_s00508_024_02372_y
ContentType Journal Article
Copyright Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.chest.2021.01.082
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1931-3543
ExternalDocumentID 33577778
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: K24 NS059892
– fundername: NINDS NIH HHS
  grantid: R01 NS042866
– fundername: NINDS NIH HHS
  grantid: R01 NS093653
GroupedDBID ---
.1-
.55
.FO
.GJ
.XZ
08P
0R~
18M
1P~
29B
2WC
354
36B
3O-
3V.
457
53G
5GY
5RE
5RS
6J9
6PF
7RV
7X7
88E
8AO
8C1
8F7
8FI
8FJ
AAEDT
AAEDW
AAKAS
AAKUH
AALRI
AAWTL
AAXUO
AAYOK
ABDBF
ABDQB
ABJNI
ABLJU
ABMAC
ABOCM
ABUWG
ACBMB
ACGFO
ACGFS
ACGUR
ACUHS
ADBBV
ADVLN
ADZCM
AENEX
AEVXI
AFCTW
AFETI
AFFNX
AFJKZ
AFKRA
AFRHN
AFTJW
AGHFR
AHMBA
AI.
AITUG
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AZQEC
B0M
BCGUY
BENPR
BKEYQ
BKNYI
BPHCQ
BVXVI
C1A
C45
CCPQU
CGR
CS3
CUY
CVF
DU5
EAP
EAS
EBC
EBD
EBS
ECM
EHN
EIF
EJD
EMK
ENC
EPT
ESX
EX3
F5P
FDB
FYUFA
GD~
H13
HMCUK
HX~
HZ~
IAO
IEA
IH2
IHR
IMI
INH
INR
IOF
IPO
J5H
K9-
L7B
LXL
LXN
M0R
M1P
M5~
MJL
MV1
N4W
N9A
NAPCQ
NEJ
NPM
O6.
O9-
OB3
OBH
ODZKP
OFXIZ
OGROG
OHH
OI-
OK1
OU.
OVD
OVIDX
P2P
PCD
PQQKQ
PROAC
PSQYO
Q~Q
RIG
ROL
SJN
SSZ
TCP
TEORI
TR2
TUS
TWZ
UKHRP
VH1
VXZ
W8F
WH7
WOQ
WOW
X7M
XOL
YFH
YHG
YOC
YQJ
Z5R
ZGI
ZRQ
ZXP
ZY1
~8M
7X8
ACVFH
ADCNI
APXCP
EFKBS
ID FETCH-LOGICAL-c511t-c866a36f0137f37809d39bff0e1737fb99c8c0f8878b2529b6880e1299b580f32
IEDL.DBID 7X8
ISICitedReferencesCount 73
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000683472800042&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1931-3543
IngestDate Sun Sep 28 03:50:14 EDT 2025
Wed Feb 19 02:26:46 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords physiology
exercise testing
dyspnea
dysautonomia
Language English
License Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c511t-c866a36f0137f37809d39bff0e1737fb99c8c0f8878b2529b6880e1299b580f32
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8727854
PMID 33577778
PQID 2489262036
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2489262036
pubmed_primary_33577778
PublicationCentury 2000
PublicationDate 2021-08-01
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Chest
PublicationTitleAlternate Chest
PublicationYear 2021
SSID ssj0001196
Score 2.6029925
Snippet Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affects tens of millions worldwide; the causes of exertional intolerance are poorly understood. The...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 642
SubjectTerms Biopsy
Exercise Test - methods
Fatigue Syndrome, Chronic - physiopathology
Female
Humans
Male
Middle Aged
Phenotype
Small Fiber Neuropathy - physiopathology
Title Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/33577778
https://www.proquest.com/docview/2489262036
Volume 160
WOSCitedRecordID wos000683472800042&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7eEF-8X-aNCL6GtU3TJk8isqEPGwMV9zaaNNmE2c7VDYZ_3pM0Y0-CYB_6UNpSck6_fsk5_T6EblkcqdwkkkiRMAKAx4hQPCChFlmapHnME-XMJtJul_f7oucX3CrfVrnERAfUeansGnkzirmVtgPAvZt8EusaZaur3kJjHW1SoDI2q9P-Si08DJ0_F3CUkFAW06XqkOvvcn5UMEGMQqfbaZX4fuOY7lvT3vvvU-6jXc8y8X2dFgdoTReHaLvj6-hH6PupqOysvMLtafmBn4p5ZtvY8YPrTp3MxnCfbLrALW_IhF-sGEcxxKXBvVqJtcJv718j3FlkYwBP3LJ_P46ycfmx0Lajrmp62V3chvOHM42fvTbCMXptt14eHom3YSAK2NgXUTxJMpoYK05oaMoDkVMhjQl0mMIRKSC4KjCAVlxGLBIyAUzQwCOEZDwwNDpBG0VZ6DOEpYhFnEsRMgNMyDqJRxIojNTAklimgga6WQ7rANLc1i6yQpezarAa2AY6rWMzmNR6HANKWQobP__D1Rdox4a8buG7RJsGXnJ9hbbUHEZmeu3yB_bdXucHStrQTA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Insights+From+Invasive+Cardiopulmonary+Exercise+Testing+of+Patients+With+Myalgic+Encephalomyelitis%2FChronic+Fatigue+Syndrome&rft.jtitle=Chest&rft.au=Joseph%2C+Phillip&rft.au=Arevalo%2C+Carlo&rft.au=Oliveira%2C+Rudolf+K+F&rft.au=Faria-Urbina%2C+Mariana&rft.date=2021-08-01&rft.eissn=1931-3543&rft.volume=160&rft.issue=2&rft.spage=642&rft_id=info:doi/10.1016%2Fj.chest.2021.01.082&rft_id=info%3Apmid%2F33577778&rft_id=info%3Apmid%2F33577778&rft.externalDocID=33577778
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-3543&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-3543&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-3543&client=summon